Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Models of Parkinson's disease (PD) based on selective neuronal death have been used to study pathogenic mechanisms underlying nigral cell death and in some instances to develop symptomatic therapies. For validation of putative neuroprotectants, a model is desirable in which the events leading to neurodegeneration replicate those occurring in the disease. We developed a human in vitro model of PD based on the assumption that dysregulated cytoplasmic dopamine levels trigger cell loss in this disorder. Differentiated human mesencephalic neuron-derived cells were exposed to methamphetamine (METH) to promote cytoplasmic dopamine accumulation. In the presence of elevated iron concentrations, as observed in PD, increased cytosolic dopamine led to oxidative stress, c-Jun N-terminal kinase (JNK) pathway activation, neurite degeneration, and eventually apoptosis. We examined the role of the mixed-lineage kinases (MLKs) in this complex degenerative cascade by using the potent inhibitor 3,9-bis[(ethylthio)methyl]-K-252a (CEP1347). Inhibition of MLKs not only prevented FeCl 2+/METH-induced JNK activation and apoptosis but also early events such as neurite degeneration and oxidative stress. This broad neuroprotective action of CEP1347 was associated with increased expression of an oxidative stress-response modulator, activating transcription factor 4. As a functional consequence, transcription of the cystine/glutamate and glycine transporters, cellular cystine uptake and intracellular levels of the redox buffer glutathione were augmented. In conclusion, this new human model of parkinsonian neurodegeneration has the potential to yield new insights into neurorestorative therapeutics and suggests that enhancement of cytoprotective mechanisms, in addition to blockade of apoptosis, may be essential for disease modulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,047
An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress
Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00105-9 · Cited by 3,323
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · cited 2×
“…neurons are under continuous oxidative stress because of the unstable nature of their neurotransmitter dopamine (Graham, 1978; Maker et al., 1981), the adverse effects of which are further enhanced by high concentrations of iron in the substantia nigra (SN) (for review, see Zecca et al., 2004).”
BackgroundPathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Self-citationBlum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126 · cited 1×
“Nigral dopaminergic neurons are under continuous oxidative stress because of the unstable nature of their neurotransmitter dopamine (Graham, 1978; Maker et al., 1981), the adverse effects of which are further enhanced by high concentrations of iron in the substantia nigra (SN) (for review, see…”
BackgroundSulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688 · cited 1×
“Alternatively , because the majority of intracellular dopamine is stored in synaptic vesicles (Sulzer et al., 1996), oxidative stress in this model could be restricted to the neurites, sparing the neuronal somata.”
BackgroundGlutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597
Self-citationDopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., & Moore, R. Y. (1982) · Brain Research · doi:10.1016/0006-8993(82)90198-6 · Cited by 479
Hirsch, T., Marchetti, P., Susin, S. A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M., & Kroemer, G. (1997) · Oncogene · doi:10.1038/sj.onc.1201324 · Cited by 461
Cubells, J., Rayport, S., Rajendran, G., & Sulzer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448
Activation of Phosphatidylinositol-3′ Kinase by Src-Family Kinase SH3 Binding to the p85 Subunit
Pleiman, C. M., Hertz, W. M., & Cambier, J. C. (1994) · Science · doi:10.1126/science.8128248 · Cited by 436
Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 426
Sulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K., & Brundin, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205518200 · Cited by 352
Self-citationThe Relevance of Iron in the Pathogenesis of Parkinson's Disease
GÖTZ, M. E., DOUBLE, K., GERLACH, M., YOUDIM, M. B. H., & RIEDERERE, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.017 · Cited by 342
Larsen, K. E., Fon, E. A., Hastings, T. G., Edwards, R. H., & Sulzer, D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08951.2002 · Cited by 335
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313 · cited 1×
“Neuromelanin, a dark pigment produced in catecholaminergic neurons of the human SN and locus ceruleus, acts as a storage system for iron in dopaminergic neurons (Zecca et al., 2002) and has been found to associate with large amounts of iron in diseased nigral tissue (Jellinger et al., 1992, 1993).”
BackgroundThe Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Lotharius, J., & O'Malley, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005385200 · Cited by 306
Self-citationRole of dopamine in the neurotoxic effects of methamphetamine.
Schmidt, C. J., Ritter, J. K., Sonsalla, P. K., Hanson, G. R., & Gibb, J. W. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22853-1 · Cited by 300
Maroney, A. C., Glicksman, M. A., Basma, A. N., Walton, K. M., Knight, E., Murphy, C. A., Bartlett, B. A., Finn, J. P., Angeles, T., Matsuda, Y., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00104.1998 · Cited by 293
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Methamphetamine-induced neuronal damage: A possible role for free radicals
De Vito, M. J., & Wagner, G. C. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90130-5 · Cited by 270
Saporito, M. S., Brown, E. M., Miller, M. S., & Carswell, S. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37972-8 · Cited by 266
Maker, H. S., Weiss, C., Silides, D. J., & Cohen, G. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb01631.x · Cited by 256
Saporito, M. S., Thomas, B. A., & Scott, R. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751200.x · Cited by 232
Xia, X. G., Harding, T., Weller, M., Bieneman, A., Uney, J. B., & Schulz, J. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181182298 · Cited by 231
Glutathione depletion and oxidative stress
Mytilineou, C., Kramer, B. C., & Yabut, J. A. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00018-4 · Cited by 223
beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation
Troy, C. M., Rabacchi, S. A., Xu, Z., Maroney, A. C., Connors, T. J., Shelanski, M. L., & Greene, L. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00218.x · Cited by 223
Ricaurte, G. A., Seiden, L. S., & Schuster, C. R. (1984) · Brain Research · doi:10.1016/0006-8993(84)91221-6 · Cited by 212
CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase Family
Maroney, A. C., Finn, J. P., Connors, T. J., Durkin, J. T., Angeles, T., Gessner, G., Xu, Z., Meyer, S. L., Savage, M. J., Greene, L. A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011601200 · Cited by 204
(1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.01901.x · Cited by 190
Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., & Yodoi, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6689 · Cited by 174
Dringen, R., & Hamprecht, B. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041375.x · Cited by 164
Self-citationTreatment of mice with methamphetamine produces cell loss in the substantia nigra
Sonsalla, P. K., Jochnowitz, N. D., Zeevalk, G. D., Oostveen, J. A., & Hall, E. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00995-x · Cited by 161
Wang, W., Shi, L., Xie, Y., Ma, C., Li, W., Su, X., Huang, S., Chen, R., Zhu, Z., Mao, Z., et al. (2004) · Neuroscience Research · doi:10.1016/j.neures.2003.10.012 · Cited by 160
Bozyczko‐Coyne, D., O'Kane, T. M., Wu, Z., Dobrzanski, P., Murthy, S., Vaught, J. L., & Scott, R. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00294.x · Cited by 151
Intracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells
Mosharov, E. V., Gong, L.-W., Khanna, B., Sulzer, D., & Lindau, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05835.2003 · Cited by 145
The true face of JNK activation in apoptosis
Lin, A., & Dibling, B. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00014.x · Cited by 144
Mixed-Lineage Kinases: A Target for the Prevention of Neurodegeneration
Wang, L. H., Besirli, C. G., & Johnson, E. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121840 · Cited by 144
Cadet, J. L., Ordonez, S. V., & Ordonez, J. V. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199702)25:2<176::aid-syn8>3.0.co;2-9 · Cited by 130
The neuromelanin of human substantia nigra and its interaction with metals
Zecca, L., Tampellini, D., Gatti, A., Crippa, P. R., Eisner, M., Sulzer, D., Ito, S., Fariello, R. G., & Gallorini, M. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200055 · Cited by 110
Saporito, M. S., Hudkins, R. L., & Maroney, A. C. (2002) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70081-x · Cited by 108
Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes
Wagner, G. C., Lucot, J. B., Schuster, C. R., & Seiden, L. S. (1983) · Brain Research · doi:10.1016/0006-8993(83)90602-9 · Cited by 104
Harris, C. A., Deshmukh, M., Tsui-Pierchala, B., Maroney, A. C., & Johnson, E. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00103.2002 · Cited by 102
Roux, P. P., Dorval, G., Boudreau, M., Angers-Loustau, A., Morris, S. J., Makkerh, J., & Barker, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203428200 · Cited by 101
The Role of c‐Jun N‐Terminal Kinase (JNK) in Parkinson's Disease
Peng, J., & Andersen, J. (2003) · IUBMB Life · doi:10.1080/1521654031000121666 · Cited by 91
Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats.
Wagner, G. C., Carelli, R. M., & Jarvis, M. F. (1985) · PubMed · Cited by 80
Specific Modulation of Astrocyte Inflammation by Inhibition of Mixed Lineage Kinases with CEP-1347
Falsig, J., Pörzgen, P., Lotharius, J., & Leist, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2762 · Cited by 77
Self-citationA Single Methamphetamine Administration Rapidly Decreases Vesicular Dopamine Uptake
Brown, J. M., Riddle, E. L., Sandoval, V., Weston, R. K., Hanson, J. E., Crosby, M. J., Ugarte, Y. V., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.2.497 · Cited by 75
Jayanthi, S., McCoy, M. T., Ladenheim, B., & Cadet, J. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.1124 · Cited by 66
Cadet, J. L., Ali, S. F., & Epstein, C. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21827.x · Cited by 61
In Vivo and in Vitro Evidence for Extracellular Caspase Activity Released from Apoptotic Cells
Hentze, H., Schwoebel, F., Lund, S., Kehl, M., Ertel, W., Wendel, A., Jäättelä, M., & Leist, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4918 · Cited by 59
Self-citationMoszczyńska, A., Turenne, S. D., & Kish, S. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00711-3 · Cited by 59
Glicksman, M. A., Chiu, A. Y., Dionne, C. A., Harty, M. W., Kaneko, M., Murakata, C., Oppenheim, R. W., Prevette, D. M., Sengelaub, D. R., Vaught, J. L., et al. (1998) · Journal of Neurobiology · Cited by 57
Mice with Partial Deficiency of c-Jun Show Attenuation of Methamphetamine-Induced Neuronal Apoptosis
Deng, X., Jayanthi, S., Ladenheim, B., Krasnova, I. N., & Cadet, J. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.993 · Cited by 51
Maroney, A. C., Lipfert, L., Forbes, M. E., Glicksman, M. A., Neff, N. T., Siman, R., & Dionne, C. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020540.x · Cited by 49
CEP-1347/KT7515, a JNK pathway inhibitor, supports the in vitro survival of chick embryonic neurons
Borasio, G. D., Horstmann, S., Anneser, J. M. H., Neff, N. T., & Glicksman, M. A. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00034 · Cited by 44
Saporito, M. S., Brown, E. R., Carswell, S., DiCamillo, A., Miller, M. S., Murakata, C., Neff, N. T., Vaught, J. L., & Haun, F. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00059-1 · Cited by 43
Methamphetamine-induced Apoptosis in a CNS-derived Catecholaminergic Cell Line
Choi, H. J., Yoo, T. M., Chung, S. Y., Yang, J., Kim, J.-I., Ha, E. S., & Hwang, O. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15026-6 · Cited by 33
Reserpine inhibits amphetamine action in ventral midbrain culture.
Sulzer, D. L., Remy, C., & Rayport, S. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08716-4 · Cited by 29
AP-1 DNA-binding activation by methamphetamine involves oxidative stress
Sheng, P., Wang, X.-B., Ladenheim, B., Epstein, C., & Cadet, J. L. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199611)24:3<213::aid-syn2>3.0.co;2-h · Cited by 27
Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine
Ricaurte, G. A. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90228-9 · Cited by 26
Açıkgöz, O., Gönenç, S., Gezer, S., et al. (2001) · Neurotoxicity Research · doi:10.1007/bf03033266 · Cited by 23
Methamphetamine: Toxicity to dopaminergic neurons.
Seiden, L. S. (1985) · PsycEXTRA Dataset · doi:10.1037/e473072004-001 · Cited by 23
Boll, J. B., Geist, M. A., Schierle, G. S. K., Petersen, K., Leist, M., & Vaudano, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02198.x · Cited by 15
Self-citationActivation of the c‐Jun N Terminal Kinase Pathway in an Animal Model of Parkinson's Disease
Willesen, M. G., Gammeltoft, S., & Vaudano, E. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04640.x · Cited by 11
Neuromelanin and Nigrostriatal Dopamine Neuron Degeneration
Jellinger, K. A., Kienzl, E., Rumpelmair, G., Riederer, P. F., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13433.x · Cited by 8
Cited by
Complexity of dopamine metabolism
Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 663
Methamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Rapid, complete and large‐scale generation of post‐mitotic neurons from the human LUHMES cell line
Scholz, D., Pöltl, D., Genewsky, A., Weng, M., Waldmann, T., Schildknecht, S., & Leist, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07255.x · Cited by 337
Self-citationRole of dopamine in the pathophysiology of Parkinson’s disease
Zhou, Z. D., Yi, L. X., Wang, D. Q., Lim, T. M., & Tan, E. K. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00378-6 · Cited by 308
Metadata
- Authors
- Lotharius, J., Falsig, J., van Beek, J., Payne, S., Dringen, R., Brundin, P., & Leist, M.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-07-06
- Volume
- 25
- Issue
- 27
- Pages
- 6329-6342
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1982600877
- Cited by
- 262
- References
- 68
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.